150 related articles for article (PubMed ID: 16854955)
21. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
Cooper CL; Mills E; Angel JB
AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
[TBL] [Abstract][Full Text] [Related]
22. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus.
Neff GW; Shire NJ; Rudich SM
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S50-5. PubMed ID: 16265614
[TBL] [Abstract][Full Text] [Related]
23. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
Weissbrich B; Langmann P; Schubert J; Jassoy C; Klinker H
Eur J Med Res; 2003 Nov; 8(11):495-8. PubMed ID: 14644704
[TBL] [Abstract][Full Text] [Related]
24. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
25. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356
[TBL] [Abstract][Full Text] [Related]
26. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
[TBL] [Abstract][Full Text] [Related]
27. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
[TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
29. Liver enzymes elevation after HAART in HIV-HCV co-infection.
Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
[TBL] [Abstract][Full Text] [Related]
30. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients.
Lichterfeld M; Schmeisser N; Qurishi N; Vogel M; Brackmann HH; Spengler U; Rockstroh JK
J Infect; 2005 Apr; 50(3):221-8. PubMed ID: 15780416
[TBL] [Abstract][Full Text] [Related]
32. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus and hepatitis C virus co-infection.
Vlahakis SR
J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
[TBL] [Abstract][Full Text] [Related]
34. The liver in HIV in Africa.
Feld JJ; Ocama P; Ronald A
Antivir Ther; 2005; 10(8):953-65. PubMed ID: 16430201
[TBL] [Abstract][Full Text] [Related]
35. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
36. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
[TBL] [Abstract][Full Text] [Related]
37. HIV and hepatitis C virus co-infection.
Rockstroh JK; Spengler U
Lancet Infect Dis; 2004 Jul; 4(7):437-44. PubMed ID: 15219554
[TBL] [Abstract][Full Text] [Related]
38. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
[TBL] [Abstract][Full Text] [Related]
39. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
[TBL] [Abstract][Full Text] [Related]
40. Reversibility of cirrhosis in HIV/HBV coinfection.
Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]